Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
89 hedge funds and large institutions have $7.24M invested in Ampio Pharmaceuticals Inc. in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 10 closing their positions.
1,005% more call options, than puts
Call options by funds: $221K | Put options by funds: $20K
80% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 10
31% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 16
10% more funds holding
Funds holding: 81 → 89 (+8)
18% less capital invested
Capital invested by funds: $8.82M → $7.24M (-$1.58M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$341K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$212K |
| 3 |
MA
Montag & Associates
Atlanta,
Georgia
|
+$94.7K |
| 4 |
SFS
Strategic Financial Services
Utica,
New York
|
+$71.7K |
| 5 |
NFG
Noven Financial Group
Denver,
Colorado
|
+$63.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$220K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$205K |
| 3 |
CCMW
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
|
-$53.6K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$51K |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$50K |
AMPE Hedge Fund Activity: Q4 2018 in Review
89 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2018, worth a combined $7.24M — down 18% from $8.82M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new AMPE positions and 10 closed out — a net gain of 8 holders — while 21 added to existing stakes and 16 trimmed.
The largest buyer was GSA Capital Partners, opening a new position worth an estimated $341K. The largest seller was Russell Investments Group, exiting entirely with an estimated $220K sold.
- 89 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2018, up from 81 in Q3 2018.
- Funds reported $7.24M of Ampio Pharmaceuticals Inc. stock for Q4 2018, down 18% quarter-over-quarter.
- 18 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2018 and 10 closed out, a net change of +8 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q4 2018 was GSA Capital Partners, an estimated $341K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q4 2018 was Russell Investments Group, an estimated $220K sold.
Based on aggregated 13F filings for Q4 2018.